(INNE)
ATIBUCLIMAB(INNF)
ATIBUCLIMAB(INND)
ATIBUKLIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS CD14, MEMBRANE (MCD14) AND SOLUBLE (SCD14)], CHIMERIC MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN CHIMERIC (1-442) [VH MUS MUSCULUS (MUSMUS IGHV3-2*02 (95.9%) -(IGHD) -MUSMUS IGHJ3*01 (92.9%) A128>S (115)) CDR-IMGT [9.7.8] (26-34.52-58.97- 104) (1-115) -HOMO SAPIENS IGHG4*01 (100%), CH1 (116- 213),HINGE 1-12 (214-225), CH2 (226-335), CH3 (336-440), CHS (441-442)) (116-442)], (129-218')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-218') [V-KAPPA MUS MUSCULUS (MUSMUS IGKV3-5*01 (97.0%) -IGKJ2*01 (100%)) CDR-IMGT [10.3.9] (27-36.54-56.93-101) (1'-111') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (157), V101 (195) (112'-218')]; DIMER (221-221":224-224")-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-DG44 CELL LINE, GLYCOFORM ALFA; PROPOSED INN LIST 124-COVID, REC. LIST 85(WHO)
IC14, (RECOMBINANT CHIMERIC MAB AGAINST HUMAN CD14)(PCHC)
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD14 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IC14 GAMMA4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IC14 KAPPA-CHAIN, DIMER(PCHC)
ATIBUCLIMABUM(INN)